summary
Introduced
01/09/2025
01/09/2025
In Committee
03/21/2025
03/21/2025
Crossed Over
Passed
Dead
Introduced Session
Potential new amendment
104th General Assembly
Bill Summary
Amends the Illinois Controlled Substances Act. Schedules xylazine as a Schedule III controlled substance. Provides that notwithstanding the scheduling of xylazine as a Schedule III controlled substance, xylazine shall not be considered a controlled substance when: (1) used by licensed Illinois veterinarians dispensing or prescribing for, or administering to, a nonhuman species of a drug containing xylazine that has been approved by the U.S. Food and Drug Administration; (2) used by licensed Illinois veterinarians dispensing or prescribing for, or administering to, a nonhuman species that is permissible under the Federal Food, Drug, and Cosmetic Act; (3) manufactured, distributed, or used as an active pharmaceutical ingredient for manufacturing an animal drug approved under the Federal Food, Drug, and Cosmetic Act; (4) used by a licensed certified euthanasia technician employed by a certified euthanasia agency; or (5) used by a wildlife biologist engaged in legal or authorized fieldwork under the indirect supervision of a veterinarian.
AI Summary
This bill amends the Illinois Controlled Substances Act to schedule xylazine (a sedative and muscle relaxant typically used in veterinary medicine) as a Schedule III controlled substance, while simultaneously creating specific exemptions for its use. The bill allows xylazine to be used without being considered a controlled substance in five specific scenarios: (1) when used by licensed Illinois veterinarians administering FDA-approved drugs containing xylazine to non-human animals, (2) when used by veterinarians for non-human species in compliance with the Federal Food, Drug, and Cosmetic Act, (3) when manufactured or distributed as an active ingredient for FDA-approved animal drugs, (4) when used by licensed euthanasia technicians employed by certified euthanasia agencies, and (5) when used by wildlife biologists conducting authorized fieldwork under indirect veterinary supervision. These exemptions ensure that xylazine can continue to be used for legitimate veterinary and scientific purposes while still being regulated as a controlled substance to prevent potential misuse.
Committee Categories
Justice
Sponsors (5)
Last Action
House Committee Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee (on 03/21/2025)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.ilga.gov/legislation/BillStatus.asp?DocNum=77&GAID=18&DocTypeID=HB&SessionID=114&GA=104 |
| House Amendment 001 | https://www.ilga.gov/legislation/104/HB/10400HB0077ham001.htm |
| BillText | https://www.ilga.gov/legislation/104/HB/10400HB0077.htm |
Loading...